Sponsor:
University of Virginia
Code:
NCT03441438
Conditions
Aspirin-Sensitive Asthma With Nasal Polyps
Samter's Syndrome
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Accepted
Interventions
Water
Red wine
Polyphenolic Compounds
Brief summary:
Conditions
Aspirin-Sensitive Asthma With Nasal Polyps
Samter's Syndrome
Study ID
NCT03441438
Start date
May 1, 2018
Status verified date
May, 2018
Completion date
Sep 1, 2018
Anticipated
Primary completion date
Sep 1, 2018
Anticipated
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Accepted
Enrollment
60 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Basic Science
Arms
active comparator: Control
active comparator: Aspirin Tolerant Asthma
active comparator: Aspirin Intolerant Asthma / AERD
Interventions
Water
Red wine
Polyphenolic Compounds
Primary outcome measure
Central contacts
Locations
University of Virginia
Recruiting
Charlottesville, Virginia, United States, 22908
Contacts
Sponsor
University of Virginia
Last update posted
May 7, 2018
Last verified
May, 2018
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Virginia on 2018-05-07.